Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
about
Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fractionNeuregulin as a heart failure therapy and mediator of reverse remodelingErbB2 signaling at the crossing between heart failure and cancerSIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic ratsCardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular riskGene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats.Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling.Signalling between microvascular endothelium and cardiomyocytes through neuregulin.Structural changes in the myocardium during diabetes-induced cardiomyopathy.Novel drug targets in clinical development for heart failure.The roles of neuregulin-1 in cardiac development, homeostasis, and disease.New Targets in the Drug Treatment of Heart Failure.Diabetic cardiomyopathy: role of the E3 ubiquitin ligase.Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-β dependent manner.Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Neuregulin improves response to glucose tolerance test in control and diabetic rats.Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
P2860
Q26853363-0CC8F863-8C25-4FB2-A9AE-0A6039286ADAQ26991903-B1F36651-1E36-4313-8365-AEDE35B2D758Q28075244-D49D9C93-4F82-4492-AE98-008D9CD9FBA6Q36200567-9C8F4B0B-A9A2-49C0-AA6A-ABDF8A68A107Q36307139-5EA9C613-8F9C-432E-84F9-49C2EE41E8E5Q36320281-8C782696-6234-41B8-9B00-6615FF429787Q36741562-18DC6021-DE56-44BD-BCA1-D39FDF1F45F9Q36775652-74465A36-0E64-48F4-9BF6-53FE5D479739Q37288691-DD24C71A-1C52-47F9-B9C1-EBCC66C96115Q37698825-0DC23E0A-6289-4432-88E3-D05887697F80Q37707158-C2739521-0D82-49B1-BAA6-CFED0938B506Q38087253-36B44A8A-2593-429F-AE77-E1E4075AB856Q38202895-CFEC3D9B-D8AE-4BAA-9D2E-C1476E0FA893Q38448410-B15B6D7C-AA72-459A-A99E-D364AA375969Q38667210-707A3CBB-F74C-44D7-81B8-37CA9AAEDA0EQ38687425-8BF2F3AE-08DF-4F5E-9215-4E1F8CBA55D7Q41939381-A463DB3D-CF5F-406B-B90E-495F5AE2AE23Q42061949-54B65545-AC86-40ED-834A-8E3CBCC1F428Q43180714-BAFF0B49-A262-435F-A64B-CCC0B6D10FA5Q47931199-0D6FD0F1-4CD2-425E-A4A2-78DD496F226EQ50223516-1A927C65-F4DE-4B31-94F9-4542AF56E180Q51760757-062EF473-3344-4C6E-A8C5-24DFCB2C08F9Q54225414-41647332-CC2F-4D1B-87F5-7F2B505FAF0BQ57805025-AA760791-6084-476D-B06F-8FD9AA3DCCA9
P2860
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@ast
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@en
type
label
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@ast
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@en
prefLabel
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@ast
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@en
P2093
P2860
P356
P1476
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.
@en
P2093
Bingong Li
Jingtian Peng
Menghong Wang
Yunfeng Wei
Zeqi Zheng
P2860
P2888
P356
10.1186/1475-2840-10-69
P407
P577
2011-07-29T00:00:00Z
P5875
P6179
1034640764